Regencell Bioscience Holdings Limited (NASDAQ: RGC)
$5.9000
+0.2500 ( +0.53% ) 82.7K
Regencell Bioscience Holdings Ltd is engaged in the research, development and commercialization of traditional Chinese medicine. The medicines are used for the treatment of neurocognitive disorders and degeneration.
Market Data
Open
$5.9000
Previous close
$5.6500
Volume
82.7K
Market cap
$73.52M
Day range
$5.7210 - $6.2350
52 week range
$3.0300 - $32.4400
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 20-f | Annual reports | 72 | Oct 25, 2024 |
| 6-k | Form 6-K | 2 | Jun 20, 2024 |
| 6-k | Form 6-K | 2 | Jan 02, 2024 |
| 6-k | Form 6-K | 2 | Dec 15, 2023 |